MedTrace Logo

Evaluating Health Outcomes and QOL After ALI Among Participants of the ALTA, OMEGA, EDEN, and SAILS ARDS Network Trials

NCT00719446 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 922

Last updated 2015-09-01

No results posted yet for this study

Summary

Acute lung injury (ALI) is a severe lung condition that causes respiratory failure. The ARDS Network (ARDSNet) is a National Heart, Lung, and Blood Institute-sponsored network that is focused on improving treatments for people with ALI and a similar condition called acute respiratory distress syndrome (ARDS). This study will evaluate participants who were enrolled in one of three ARDSNet studies to examine how the treatments carried out in the prior studies affect participants' long-term health outcomes and quality of life.

Conditions

  • Respiratory Distress Syndrome, Adult

Sponsors & Collaborators

Principal Investigators

  • Dale M. Needham, MD, PhD · Johns Hopkins University

  • Ramona O Hopkins, PhD · Intermountain Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-10-31
Primary Completion
2014-10-31
Completion
2014-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00719446 on ClinicalTrials.gov